Steatosis and hepatic markers before and shortly after bariatric surgery

Annals of Clinical Biochemistry

Volumn 44, Issue 1, 2007, Pages 63-69

  De Abreu, M R A ^a   Ramos, A P P ^b   Vendramini, R C ^a   Brunetti, I L ^a   Pepato, M T ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; CHOLINESTERASE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; HUMAN; LIVER FUNCTION TEST; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BARIATRIC SURGERY; BILIRUBIN; BIOLOGICAL MARKERS; CHOLINESTERASES; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MULTIVARIATE ANALYSIS; OBESITY, MORBID; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846501409     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307779596002     Document Type: Article

References (52)

1. Halpern A. Obesidade. São Paulo: Contexto, 1999; 67-9
2. Manson EE. Vertical banded gastroplasty for obesity. Arch Surch 1982; 117: 701-6
3. Garrido Jr AB. Cirurgia da Obesidade. São Paulo: Atheneu, 2002; 321
4. Cotran RS, Kumar V, Robbins SL. Patologia Estrutural e Funcional. 6th edn. Rio de Janeiro: Guanabara Koogan, 2000; 33-5
5. Del Gaudio A. Liver damage in obese patients. Obes Surg 2002; 12: 802-4
6. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 2004; 5: 27-42
7. Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26: 98-106
8. Salmon PA, Reedyk L. Fatty metamorphosis in patients with jejunoileal bypass. Surg Gynecol Obstet 1975; 141: 75-84
9. Garg A, Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab 2002; 87: 3019-22
10. Clouston AD, PowelL EE. Nonalcoholic fatty liver disease: is all the fat bad? Intern Med J. 2004; 34: 187-91
11. Clain DJ, Lefkowitch JH. Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 1987; 16: 239-52
12. Fitz J, Gregory MD. Approach to the patient with suspected liver disease. In: Fredman SL, McQuaid KR, Grendell JM, eds. Current Diagnosis & Treatment in Gastroenterology. New York: McGraw-Hill, 2003; 189-95
13. Zanin Jr I, Mattos AA, Perin C, Ramos GZ. The importance of AST/ALT rate in nonalcoholic steatohepatitis diagnosis. Arq Gastroenterol 2002; 39: 22-6
14. Miller O, Gonçalves RR. Laboratório para o clínico. 5th edn. Rio de Janeiro: Atheneu, 1995; 58-65
15. Brasil. Ministério da Saúde. Centros Nacionais de Cirurgia Bariátrica TDF. Gastroplastia 2000, Available at http//:www.dtr2001.saúde.gov.br Accessed on 14 February 2004
16. Wroblewski F, Ladue JS. Serum glutamic-pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med 1956; 91: 569-71
17. Bergmeyer H, Bowers Jr G, Horder M, Moss DW. Provisional recommendations of IFCC methods for all measurements of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase. Clin Chem 1977; 23: 887-99
18. Recommendation of the German Society for Clinical Chemistry. Standardisation of methods for the estimation of enzyme activities in biological fluids. Experimental basis for the optimized standard conditions. Z Klin Chem Klin Biochem 1972; 10: 281-91
19. Pesce AJ. Lactato desidrogenase. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St Louis: Mosby, 1987; 903-6
20. Pesce AJ, Gendler SM. Gama-glutamyl transferase. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St Louis: Mosby, 1987; 1120-4
21. Kazmierczak SC, Lott JA. Alkaline phosphatase. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St Louis: Mosby, 1987; 1074-9
22. Thomas L. Clinical Laboratory Diagnostics. Frankfurt: TH-Books Veriagsgeselschaft, 1998; 192-202
23. Tolman KG, Rej R. Liver function. In: Burtis CA, Ashwood ER, eds. Tietz Fundamentals of Clinical Chemistry. 5th edn. Philadelphia: WB Saunders, 2001; 747-70
24. Mroz Jr RC. Lipids. In: Anderson SC, Cockayne S, eds. Clinical Chemistry Concepts & Applications. New York: McGraw-Hill, 2003; 179-202
25. Aldrich JE. Clinical enzymology. In: Anderson SC, Cockayne S, eds. Clinical Chemistry Concepts & Applications. New York: McGraw-Hill, 2003; 261-84
26. Johnson AM, Rohlfs EM, Silverman LM. Proteins. In: Burtis CA, Ashwood ER, eds. Tietz Fundamentals of Clinical Chemistry. 5th edn. Philadelphia: WB Saunders, 2001; 325-51
27. Schumann G, Bonora R, Ceriotti F, et al. IFCC primary reference procedure for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 5: Reference procedure for the measurement of catalytic concentrations of aspartate aminotransferase. Clin Chem Lab Med 2002; 40: 725-33
28. Fischbach F, Zawta B. Age-dependent reference limits of several enzymes in plasma at different measuring temperatures. Klin Lab 1992; 38: 555-61
29. Young DS. Effects of Drugs on Clinical Laboratory Tests. 3th edn Washington (DC): AACC Press, 1990; 35-48
30. Schaefer EJ, McNamara J. Overview of the diagnosis and treatment of lipid disorders. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of Lipoprotein Testing. Washington (DC): AACC Press, 1997; 25-48
31. Riella MC. Suporte Nutricional Parenteral e Enteral. 2nd edn. Rio de Janeiro: Guanabara Koogan, 1993; 472
32. Courcoulas SA, Schuchert M, Gatti G, Luketich J. The relationship of surgeon and hospital volume to outcome after gastric bypass surgery in Pennsylvania: a 3-year summary. Surgery 2003; 134: 613-21
33. Capella JF, Capella RF. The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am J Surg 1996; 171: 74-9
34. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. Can Med Assoc J 2005; 172: 899-905
35. Russo WM, Jacobson IM. Nonalcoholic fatty liver disease. Hosp Physician 2002; 67: 36-41
36. Stranges S, Dorn JM, Muti P, et al. Body fat distribution, relative weight, and liver enzymes levels: a population-based study. Hepatology 2004; 39: 754-63
37. Busetto L, Tregnaghi A, De Marchi F, et al. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res 2002; 10: 408-11
38. Choi JW. Association between elevated serum hepatic enzyme activity and total body fat in obese humans. Ann Clin Lab Sci 2003; 33: 257-64
39. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002; 16: 663-78
40. Satheesh N. Nonalcoholic fatty liver disease from the perspective of an internist. Oschsner J 2003; 4: 92-7
41. Lindor KD. NASH and NAFL in 2003. Accessed 24 March 2005 at http://www.omge.org/?publications
42. Giboney P. Mildly elevated liver transaminases levels in the asymptomatic patient. Am Fam Physician 2005; 71: 1105-10
43. Silverman EM, Sapala JA, Appelman HD. Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathol 1995; 104: 23-31
44. Torgerson JS, Lindroons AK, Sjostrom CD, Olsson R, Lissner L, Sjostrom L. Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome? Obes Res 1997; 5: 105-14
45. Limdi JK, Hyde GM. Evaluation of abnormal liver functional tests. Postgrad Med J 2003; 79: 307-12
46. Nomura F, Ohnishi K, Koen H, et al. Serum cholinesterase in patients with fatty liver. J Clin Gastroenterol 1986; 8: 599-602
47. Kutty KM, Huang SN, Kean KT. Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice. Experientia 1981; 37: 1141-2
48. Caballeria J, Rodes J. Nonalcoholic steatohepatitis. Med Clin (Barc) 2003; 120: 670-5
49. Renquist KE, Cullen JJ, Barnes D, Tang S, Doherty C, Manson EE. The effect of follow-up on reporting success for obesity surgery. Obes Surg 1995; 5: 285-92
50. Abreu MRA. Evaluation of the Biochemical Markers in Bariatric Surgery: Short Period. [Masters Dissertation]. Araraquara: Faculty of Pharmaceutical Sciences, UNESP, 2005
51. Dixon JB, O'Brien PE. Lipid profile in the severely obese: change with weight loss after lap-band surgery. Obes Res 2002; 10: 903-10
52. Sekar N, Veldhuis JD. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulose-luteal cells. Am J Physiol Endocrinol Metab 2004; 287: E128-35